AGA
Altrinsic Global Advisors Portfolio holdings
AUM
$2.76B
This Quarter Return
+1.83%
1 Year Return
+17.53%
3 Year Return
+48.92%
5 Year Return
+91.21%
10 Year Return
+153.34%
AUM
$3.29B
AUM Growth
+$3.29B
(+3.6%)
Cap. Flow
+$73.1M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
56.45%
Holding
84
New
2
Increased
26
Reduced
32
Closed
4
Top Buys
| 1 |
Everest Group
EG
|
$166M |
| 2 |
Tencent Music
TME
|
$55.4M |
| 3 |
Alibaba
BABA
|
$53.7M |
| 4 |
Baidu
BIDU
|
$35.3M |
| 5 |
Chubb
CB
|
$20.7M |
Top Sells
| 1 |
Cognizant
CTSH
|
$98.7M |
| 2 |
Aon
AON
|
$45.1M |
| 3 |
Trip.com Group
TCOM
|
$42.8M |
| 4 |
Comcast
CMCSA
|
$35M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$22.4M |
Sector Composition
| 1 | Financials | 29.3% |
| 2 | Communication Services | 18.42% |
| 3 | Technology | 11.6% |
| 4 | Consumer Discretionary | 11.24% |
| 5 | Healthcare | 11.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
51
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $3.93M | 0.12% |
68,485
| – | – |
|
|
AERI
52
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.84M | 0.12% |
240,000
| – | – |
|
53
Lantheus
LNTH
$3.73B
| $3.59M | 0.11% |
130,000
| – | – |
|
54
Brookdale Senior Living
BKD
$1.83B
| $3.5M | 0.11% |
442,452
| – | – |
|
|
ICPT
55
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.37M | 0.1% |
168,800
| – | – |
|
56
Xenon Pharmaceuticals
XENE
$2.98B
| $3.17M | 0.1% |
170,000
| – | – |
|
57
Elevance Health
ELV
$71.8B
| $3.09M | 0.09% |
+8,100
| New | +$3.09M |
|
58
Jazz Pharmaceuticals
JAZZ
$7.75B
| $2.67M | 0.08% |
15,000
| – | – |
|
59
Fate Therapeutics
FATE
$120M
| $2.6M | 0.08% |
30,000
| – | – |
|
60
Sangamo Therapeutics
SGMO
$157M
| $2.59M | 0.08% |
216,500
| – | – |
|
|
ITCI
61
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.45M | 0.07% |
60,000
| – | – |
|
62
Axogen
AXGN
$743M
| $2.38M | 0.07% |
110,000
| – | – |
|
63
ProQR Therapeutics
PRQR
$237M
| $2.17M | 0.07% |
321,360
| – | – |
|
64
Envista
NVST
$3.52B
| $2.16M | 0.07% |
50,000
| – | – |
|
65
Merit Medical Systems
MMSI
$5.36B
| $1.89M | 0.06% |
29,202
-10,000
| -26% | -$647K |
|
66
MacroGenics
MGNX
$112M
| $1.88M | 0.06% |
70,000
| – | – |
|
67
Kura Oncology
KURA
$686M
| $1.88M | 0.06% |
90,000
+20,000
| +29% | +$417K |
|
|
AGTC
68
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.47M | 0.04% |
376,900
| – | – |
|
69
Atara Biotherapeutics
ATRA
$84.6M
| $1.4M | 0.04% |
90,000
+10,000
| +13% | +$156K |
|
70
JD.com
JD
$44.1B
| $1.22M | 0.04% |
15,248
-151
| -1% | -$12.1K |
|
71
Cabaletta Bio
CABA
$133M
| $1.12M | 0.03% |
130,000
+10,000
| +8% | +$86K |
|
72
Delcath Systems
DCTH
$385M
| $1.01M | 0.03% |
80,000
+30,000
| +60% | +$378K |
|
73
Tenaris
TS
$18.9B
| $963K | 0.03% |
44,005
-437
| -1% | -$9.56K |
|
74
Infosys
INFY
$69.7B
| $955K | 0.03% |
45,094
-20,135
| -31% | -$426K |
|
75
Vale
VALE
$43.9B
| $798K | 0.02% |
34,965
-347
| -1% | -$7.92K |
|